![Spyridon Papapetropoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Spyridon Papapetropoulos
Fondateur chez
Encephalos Life Sciences LLC
Fortune : 145 533 $ au 31/08/2026
Profil
Dr. Spyridon Papapetropoulos is a Chief Executive Officer & Executive Director at Neuphoria Therapeutics, Inc., a President, Chief Executive Officer & Director at Bionomics Ltd. and a President at Encephalos Life Sciences LLC.
He is on the Board of Directors at Neuphoria Therapeutics, Inc. and Bionomics Ltd. Dr. Papapetropoulos was previously employed as a Chairman by Lipocine, Inc., an Independent Director by Adamas Pharmaceuticals LLC, a Chief Medical Officer by Vigil Neuroscience, Inc., a Chief Development Officer, SVP & Head-Development by ACADIA Pharmaceuticals, Inc., a Chief Executive Officer by SwanBio Therapeutics, Inc., and a Chief Medical Officer & EVP-R&D by Cavion, Inc. He received his doctorate degree from the University of Patras and a doctorate degree from Semmelweis University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,32 % | 16/04/2025 | 5 999 940 ( 0,32 % ) | 124 079 $ | 31/08/2026 |
0,09 % | 17/09/2026 | 4 944 ( 0,09 % ) | 18 589 $ | 31/08/2026 |
LIPOCINE INC 0,02 % | 04/06/2025 | 1 279 ( 0,02 % ) | 2 865 $ | 31/08/2026 |
Postes actifs de Spyridon Papapetropoulos
| Sociétés | Poste | Début |
|---|---|---|
Encephalos Life Sciences LLC
 Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Fondateur | - |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Directeur Général | 05/01/2023 |
Anciens postes connus de Spyridon Papapetropoulos
| Sociétés | Poste | Fin |
|---|---|---|
| LIPOCINE INC. | Président | 16/04/2026 |
| VIGIL NEUROSCIENCE, INC. | Directeur Technique/Scientifique/R&D | 04/01/2023 |
| ADAMAS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 24/11/2021 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Directeur Général | 01/10/2020 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/09/2020 |
Formation de Spyridon Papapetropoulos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
University of Patras
 University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Semmelweis University
 Semmelweis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipocine, Inc.
 Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
Encephalos Life Sciences LLC
Encephalos Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences consulting firm | Commercial Services |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
